Form 4 for CRBU Caribou Biosciences, Inc.
Accepted 2023-01-20 00:00:00 ET · period of report 2023-01-19 · accession 0001619856-23-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-01-20 | 2023-01-19 | CRBU | Rizvi Syed Ali-aamir | Chief Medical Off | S - Sale | $6.31 | -5,627 | 59.4K | -9% | -$35.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-19 | S | D | 5,627 | $6.31 | 59,373 | D | — | — | (F1) Represents the number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units as provided in standing "sell to cover" instructions. |